Is It Time To Reassess MannKind (MNKD) After The Recent Share Price Rebound
- Wondering whether MannKind’s current share price lines up with its underlying worth, or if the market is mispricing the stock.
- The stock last closed at US$3.38, with gains of 13.0% over the past 7 days and 25.2% over the past month, while still showing a decline of 39.6% year to date and 18.0% over the past year.
- Recent coverage around MannKind has focused on its position in the Biotechs space and on how investors are assessing its long term prospects and risks. This context helps explain why the share price has seen both periods of recovery and longer term weakness.
- MannKind currently holds a valuation score of 5/6. The rest of this article will break down how different valuation approaches arrive at that result, before finishing with…
Source link
